tiprankstipranks
Trending News
More News >
Opus Genetics (IRD)
NASDAQ:IRD
US Market

Opus Genetics (IRD) Income Statement

Compare
1,264 Followers

Opus Genetics Income Statement

Last quarter (Q4 2025), Opus Genetics's total revenue was $3.87M, a decrease of -10.16% from the same quarter last year. In Q4, Opus Genetics's net income was $-16.52M. See Opus Genetics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 14.20M$ 10.99M$ 19.05M$ 39.85M$ 589.00K
Gross Profit
$ 14.14M$ 10.99M$ 19.05M$ 39.85M$ 589.00K
Operating Expenses
$ 52.80M$ 73.07M$ 29.61M$ 21.62M$ 23.29M
Depreciation and Amortization
$ 53.00K$ 10.00K$ 6.00K$ 4.00K$ 4.00K
EBITDA
$ -38.60M$ -57.52M$ -9.97M$ 18.22M$ -56.69M
Operating Income
$ -38.60M$ -62.07M$ -10.56M$ 18.23M$ -22.70M
Other Income/Expenses
$ -10.99M$ 4.54M$ 589.00K$ -23.00K$ -33.99M
Pretax Income
$ -49.59M$ -57.53M$ -9.97M$ 18.20M$ -56.69M
Net Income
$ -49.59M$ -57.53M$ -9.99M$ 17.89M$ -56.69M
Per Share Metrics
Basic EPS
$ -0.80$ -2.15$ -0.46$ 0.90$ -3.82
Diluted EPS
$ -0.80$ -2.15$ -0.46$ 0.87$ -3.82
Weighted Average Shares Outstanding
622.22M 26.72M 21.59M 19.93M 14.85M
Weighted Average Shares Outstanding (Diluted)
622.22M 26.72M 21.59M 20.60M 14.85M
Currency in USD

Opus Genetics Earnings and Revenue History